|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,473.88 |
3.28% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$62,329.05 |
2.94% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$53,736.33 |
2.54% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$50,203.29 |
2.37% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$48,496.41 |
2.29% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,167.46 |
2.28% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,988.82 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,812.15 |
2.21% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,327.20 |
2.19% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$45,373.04 |
2.14% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,619.58 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,364.32 |
2.10% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,469.97 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$44,131.95 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$44,023.10 |
2.08% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,136.24 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,880.50 |
2.07% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$43,731.00 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$43,437.08 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,165.98 |
2.04% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$42,338.08 |
2.00% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$42,014.62 |
1.98% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,693.60 |
1.97% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$41,352.84 |
1.95% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,219.51 |
1.95% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$41,001.84 |
1.94% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,719.92 |
1.92% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$40,409.88 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,345.36 |
1.91% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,153.08 |
1.90% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$38,865.59 |
1.84% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$38,940.87 |
1.84% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$38,887.35 |
1.84% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,609.98 |
1.82% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,350.25 |
1.81% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$38,207.83 |
1.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,094.50 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$38,206.64 |
1.80% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,214.17 |
1.80% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,824.14 |
1.79% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,576.84 |
1.77% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,418.76 |
1.77% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,307.58 |
1.76% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,656.01 |
1.73% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$36,641.76 |
1.73% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$36,132.27 |
1.71% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$35,979.72 |
1.70% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$35,533.31 |
1.68% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,213.46 |
1.66% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,942.82 |
1.51% |
| US Dollar |
$USD |
|
3,443 |
$3,442.77 |
0.16% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|